• Explore /
  • Poster
  • / A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.

A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.

Abstract Poster

Authors

null

Mario Javier Pineda

Ironwood Cancer and Research Centers, Gilbert, AZ

Mario Javier Pineda , Jeanne Schilder , Emily K. Hill , Deanna Gek Koon Teoh , Emma Longley Barber , Sharon E. Robertson , Anna Everett Strohl , Jiahui Xu , Masha Kocherginsky , Daniela Matei

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Uterine Cancer

Clinical Trial Registration Number

NCT02549209

Citation

J Clin Oncol 38: 2020 (suppl; abstr 6022)

DOI

10.1200/JCO.2020.38.15_suppl.6022

Abstract #

6022

Poster Bd #

193

Abstract Disclosures

Similar Posters

First Author: Christian Marth

First Author: Florence Joly

First Author: Brian M. Slomovitz

First Author: Neesha C. Dhani